Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV co-infected patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 03 May 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms EARLY HEP-C
- 27 Apr 2018 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.
- 27 Apr 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 13 Sep 2016 New trial record